Page last updated: 2024-08-17

spironolactone and bromhexine

spironolactone has been researched along with bromhexine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Bulanova, MM; Fuks, AA; Kamalov, AA; Malakhov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, EA; Orlova, YA; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Sinitsyn, VE1
Agapov, MA; Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Bulanova, MM; Dyachuk, LI; Fuks, AA; Kamalov, АА; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, ЕА; Orlova, YA; Pakhomov, PV; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Sinitsyn, VE1

Trials

1 trial(s) available for spironolactone and bromhexine

ArticleYear
[Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)].
    Kardiologiia, 2020, 12-03, Volume: 60, Issue:11

    Topics: Bromhexine; Coronavirus Infections; COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Spironolactone; Treatment Outcome

2020

Other Studies

1 other study(ies) available for spironolactone and bromhexine

ArticleYear
[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"].
    Kardiologiia, 2020, Sep-07, Volume: 60, Issue:8

    Topics: Betacoronavirus; Bromhexine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Moscow; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Spironolactone

2020